Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$87.44 - $112.11 $3.26 Million - $4.18 Million
-37,300 Reduced 91.42%
3,500 $388,000
Q3 2022

Oct 25, 2022

BUY
$84.53 - $94.96 $1.14 Million - $1.28 Million
13,500 Added 49.45%
40,800 $3.51 Million
Q2 2022

Aug 01, 2022

SELL
$83.49 - $94.64 $4.59 Million - $5.21 Million
-55,000 Reduced 66.83%
27,300 $2.49 Million
Q1 2022

Apr 27, 2022

BUY
$73.51 - $82.4 $6.05 Million - $6.78 Million
82,300 New
82,300 $6.75 Million
Q4 2021

Jan 31, 2022

SELL
$72.28 - $90.54 $2.22 Million - $2.78 Million
-30,700 Closed
0 $0
Q3 2021

Nov 02, 2021

BUY
$71.68 - $78.83 $1.9 Million - $2.09 Million
26,500 Added 630.95%
30,700 $2.31 Million
Q1 2021

May 03, 2021

BUY
$68.86 - $81.11 $261,668 - $308,218
3,800 Added 950.0%
4,200 $324,000
Q4 2020

Jan 29, 2021

BUY
$71.77 - $79.65 $28,708 - $31,860
400 New
400 $32,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Qvr LLC Portfolio

Follow Qvr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qvr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qvr LLC with notifications on news.